1Kip KE,Faxon DP,Detre KM,et al.For the investigation of the NHLBI PTCA registry.Coronary angioplasty in diabetic patients:the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry[].Circulation.1996 被引量：1
2Stein B,Weintraub WS,Gebhart S,et al.Short and long term outcome of diabetic patients undergoing coronary angioplasty[].Circulation.1995 被引量：1
3Uusitupa MIJ,Niskanen LK,Siitonen O,et al.Five-year incidence of atherosclerotic vascular disease in relation to general risk factors,insulin level and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and non-diabetic subjects[].Circulation.1990 被引量：1
4Weintraub WS,Stein B,Kosinski A,et al.Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease[].Journalism Assn of Community College.1998 被引量：1
5Holmes DR,Vlietstra RE,Smith HC,et al.Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute[].The American Journal of Cardiology.1984 被引量：1
6Kannel WB,McGee DL.Diabetes and cardiovascular disease: the Framingham Study[].The Journal of The American Medical Association.1979 被引量：1
7Douglass AM,Sethi G,Sacks J,et al.Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: A multicenter, randomized trial[].Journalism Assn of Community College.2001 被引量：1
8Stamler J,Vaccaro O,Neaton JD,et al.Diabetes, other risk factors and 12-year cardiovascular mortality for men secreened in the multiple risk factor intervention trial[].Diabetes Care.1993 被引量：1
3Cassese S, Byrne RA, Tada T, et al. Incidence and predictors of rest- enosis after coronary stenting in 10 004 patients with surveillance an- giography [ J ]. Heart ,2014,100 : 153-159. 被引量：1
4Lingman M, Albertsson P, Herlitz J, et al. The impact of hypertension and diabetes on outcome in patients undergoing percutaneous coro- nary intervention [J]. Am J Med, 2011,124 : 265-275. 被引量：1
5Kirtane A J, Ellis SG, Dawkins KD, et al. Paclitaxel-eluting coronary stents in patients with diabetes mellitus : pooled analysis from 5 ran- domized trials[ J]. J Am Coil Cardiol,2008,51:708-715. 被引量：1
6Hoffmann R, Stellbrink E, Schroder J, et al. Impact of the metabolic syndrome on angiographic and clinical events after coronary interven- tion using bare-metal or sirolimus-eluting stents [ J ]. Am J Cardiol, 2007,100 : 1347-1352. 被引量：1
7Lindsay J, Sharma AK, Canos D, et al. Preprocedure hyperglycemia is more strongly associated with restenosis in diabetic patients after per- cutaneous coronary intervention than is hemoglobin A1C[ J]. Card- iovasc Revasc Med ,2007,8 : 15-20. 被引量：1
8Woudstra P, Damman P, Beijk MA, et al. Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis[ J]. Catheter Cardiovasc Interv ,2013,81:26-33. 被引量：1
9Rosenbaum PR, Rubin DB. The central role of the propensity scole in observational studies for causal effects [ J ]. Biometrika, 1983,70:41 - 55. 被引量：1
10Pendyala LK, Loh JP, Kitabata H, et al. The impact of diabetes meUi- tus on long-term clinical outcomes after percutaneous coronary sa- phenous vein graft interventions in the drug-eluting stent era [ J ]. J Interv Cardiol,2014,27:391-398. 被引量：1
